Borviz – Bortezomib Injection
Description
BORTEZOMIB (BORVIZ) INJECTION – TREATMENT OF NUMEROUS MYELOMA AND MANTLE-CELL LYMPHOMA
Bortezomib Borviz Injection is used to treat multiple myeloma and mantle-cell lymphoma. It works by preventing or slowing the formation of cancerous growth cells.
How Bortezomib 2.5mg Borviz Injection is used.
Bortezomib 2.5mg Borviz Injection is administered as an infusion by a licensed clinical specialist. Your primary care physician will determine what percentage is necessary and how frequently you should take it. This will vary depending on what you are being treated for and may change from time to time. You should take it exactly as your PCP has instructed.
Side effects of Bortezomib 2.5mg Borviz Injection:
Weakness, queasiness, regurgitation, and loss of craving are some of the most common side effects of this medicine. You may be instructed to consume a lot of liquids on a regular basis during the treatment. You should not drive or operate heavy machinery since the medicine may cause sluggishness and wooziness. This prescription may reduce the number of platelets (red blood and white platelets) in your blood, increasing your vulnerability to diseases.
Precautions:
Before taking Bortezomib 2.5mg Borviz Injection, consult your primary care physician if you have any liver, kidney, coronary illness, or draining issues. It is critical to consult a doctor if you experience symptoms such as cognitive impairment or difficulty reasoning.
